Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Reasons for Underreporting of Uremic Pruritus in People With Chronic Kidney Disease: A Qualitative Study.

Aresi G, Rayner HC, Hassan L, Burton JO, Mitra S, Sanders C, van der Veer SN.

J Pain Symptom Manage. 2019 Oct;58(4):578-586.e2. doi: 10.1016/j.jpainsymman.2019.06.010. Epub 2019 Jun 19.

2.

Pruritus and Patient Reported Outcomes in Non-Dialysis CKD.

Sukul N, Speyer E, Tu C, Bieber BA, Li Y, Lopes AA, Asahi K, Mariani L, Laville M, Rayner HC, Stengel B, Robinson BM, Pisoni RL; CKDopps and CKD-REIN investigators.

Clin J Am Soc Nephrol. 2019 May 7;14(5):673-681. doi: 10.2215/CJN.09600818. Epub 2019 Apr 11.

PMID:
30975656
3.

The estimated glomerular filtration rate graph: another tool in the management of patients with advanced chronic kidney disease.

Rayner HC, Rosansky SJ.

Kidney Int. 2018 Jul;94(1):222. doi: 10.1016/j.kint.2018.04.016. No abstract available.

PMID:
29933851
4.

Mortality risk in patients on hemodiafiltration versus hemodialysis: a 'real-world' comparison from the DOPPS.

Locatelli F, Karaboyas A, Pisoni RL, Robinson BM, Fort J, Vanholder R, Rayner HC, Kleophas W, Jacobson SH, Combe C, Port FK, Tentori F.

Nephrol Dial Transplant. 2018 Apr 1;33(4):683-689. doi: 10.1093/ndt/gfx277.

5.

International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis.

Rayner HC, Larkina M, Wang M, Graham-Brown M, van der Veer SN, Ecder T, Hasegawa T, Kleophas W, Bieber BA, Tentori F, Robinson BM, Pisoni RL.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2000-2007. doi: 10.2215/CJN.03280317. Epub 2017 Sep 18.

6.

How Do We Improve the Quality of Life of Haemodialysis Patients? Now That's a Good Question.

Rayner HC.

Am J Nephrol. 2017;46(1):1-2. doi: 10.1159/000476080. Epub 2017 May 30. No abstract available.

7.

A programme to spread eGFR graph surveillance for the early identification, support and treatment of people with progressive chronic kidney disease (ASSIST-CKD): protocol for the stepped wedge implementation and evaluation of an intervention to reduce late presentation for renal replacement therapy.

Gallagher H, Methven S, Casula A, Thomas N, Tomson CR, Caskey FJ, Rose T, Walters SJ, Kennedy D, Dawnay A, Cassidy M, Fluck R, Rayner HC, Nation M.

BMC Nephrol. 2017 Apr 11;18(1):131. doi: 10.1186/s12882-017-0522-9.

8.

Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS.

Perl J, Karaboyas A, Morgenstern H, Sen A, Rayner HC, Vanholder RC, Combe C, Hasegawa T, Finkelstein FO, Lopes AA, Robinson BM, Pisoni RL, Tentori F.

Nephrol Dial Transplant. 2017 Mar 1;32(3):521-527. doi: 10.1093/ndt/gfw233.

9.

Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in hemodialysis patients: the DOPPS.

Lopes AA, Lantz B, Morgenstern H, Wang M, Bieber BA, Gillespie BW, Li Y, Painter P, Jacobson SH, Rayner HC, Mapes DL, Vanholder RC, Hasegawa T, Robinson BM, Pisoni RL.

Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1702-12. doi: 10.2215/CJN.12371213. Epub 2014 Oct 2.

10.

Diabetes and renal disease: who does what?

Rayner HC.

Clin Med (Lond). 2014 Feb;14(1):93. doi: 10.7861/clinmedicine.14-1-93. No abstract available.

11.

Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Rayner HC, Zepel L, Fuller DS, Morgenstern H, Karaboyas A, Culleton BF, Mapes DL, Lopes AA, Gillespie BW, Hasegawa T, Saran R, Tentori F, Hecking M, Pisoni RL, Robinson BM.

Am J Kidney Dis. 2014 Jul;64(1):86-94. doi: 10.1053/j.ajkd.2014.01.014. Epub 2014 Feb 14.

12.

Does community-wide chronic kidney disease management improve patient outcomes?

Rayner HC, Baharani J, Dasgupta I, Suresh V, Temple RM, Thomas ME, Smith SA.

Nephrol Dial Transplant. 2014 Mar;29(3):644-9. doi: 10.1093/ndt/gft486. Epub 2013 Dec 10.

PMID:
24335381
13.

Laboratory database population surveillance to improve detection of progressive chronic kidney disease.

Kennedy DM, Chatha K, Rayner HC.

J Ren Care. 2013 Sep;39 Suppl 2:23-9. doi: 10.1111/j.1755-6686.2013.12029.x.

PMID:
23941701
14.

Associations of frequency and duration of patient-doctor contact in hemodialysis facilities with mortality.

Kawaguchi T, Karaboyas A, Robinson BM, Li Y, Fukuhara S, Bieber BA, Rayner HC, Andreucci VE, Pisoni RL, Port FK, Morgenstern H, Akizawa T, Saran R.

J Am Soc Nephrol. 2013 Sep;24(9):1493-502. doi: 10.1681/ASN.2012080831. Epub 2013 Jul 25.

15.

In reply to 'Differences in blood transfusion trends between US and UK centers'.

Fuller DS, Rayner HC, Fluck RJ.

Am J Kidney Dis. 2013 Jul;62(1):182. doi: 10.1053/j.ajkd.2013.04.011. No abstract available.

PMID:
23773846
16.

Hemodialysis patient preference for type of vascular access: variation and predictors across countries in the DOPPS.

Fissell RB, Fuller DS, Morgenstern H, Gillespie BW, Mendelssohn DC, Rayner HC, Robinson BM, Schatell D, Kawanishi H, Pisoni RL.

J Vasc Access. 2013 Jul-Sep;14(3):264-72. doi: 10.5301/jva.5000140. Epub 2013 Apr 10.

PMID:
23599135
17.

Increasing the frequency of consultant ward rounds reduces hospital bed use.

Rayner HC.

BMJ. 2012 Feb 14;344:e1037. doi: 10.1136/bmj.e1037. No abstract available.

PMID:
22334546
18.

Systematic kidney disease management in a population with diabetes mellitus: turning the tide of kidney failure.

Rayner HC, Hollingworth L, Higgins R, Dodds S.

BMJ Qual Saf. 2011 Oct;20(10):903-10. doi: 10.1136/bmjqs-2011-000061. Epub 2011 Jun 30.

PMID:
21719559
19.

Tackling practice variation. Lessons from variation can help change health policy.

Rayner HC.

BMJ. 2011 Apr 8;342:d2271. doi: 10.1136/bmj.d2271. No abstract available.

PMID:
21478233
20.

The increasing use of hemodialysis catheters: evidence from the DOPPS on its significance and ways to reverse it.

Rayner HC, Pisoni RL.

Semin Dial. 2010 Jan-Feb;23(1):6-10. doi: 10.1111/j.1525-139X.2009.00675.x. No abstract available.

PMID:
20331810
21.

In good conscience--safely withholding dialysis in the elderly.

Dasgupta I, Rayner HC.

Semin Dial. 2009 Sep-Oct;22(5):476-9. doi: 10.1111/j.1525-139X.2009.00617.x. Epub 2009 Jun 25.

PMID:
19558628
22.

Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis.

Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, Rayner HC, Saito A, Sands JJ, Saran R, Gillespie B, Wolfe RA, Port FK.

Am J Kidney Dis. 2009 Mar;53(3):475-91. doi: 10.1053/j.ajkd.2008.10.043. Epub 2009 Jan 15.

PMID:
19150158
23.

A fresh start for hospital IT systems?

Rayner HC.

Br J Hosp Med (Lond). 2008 Oct;69(10):550. No abstract available.

PMID:
18949936
24.

Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study.

Saran R, Elder SJ, Goodkin DA, Akiba T, Ethier J, Rayner HC, Saito A, Young EW, Gillespie BW, Merion RM, Pisoni RL.

Ann Surg. 2008 May;247(5):885-91. doi: 10.1097/SLA.0b013e31816c4044.

PMID:
18438128
25.

Travel time to dialysis as a predictor of health-related quality of life, adherence, and mortality: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Moist LM, Bragg-Gresham JL, Pisoni RL, Saran R, Akiba T, Jacobson SH, Fukuhara S, Mapes DL, Rayner HC, Saito A, Port FK.

Am J Kidney Dis. 2008 Apr;51(4):641-50. doi: 10.1053/j.ajkd.2007.12.021. Epub 2008 Mar 3.

PMID:
18371540
26.

Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Elder SJ, Pisoni RL, Akizawa T, Fissell R, Andreucci VE, Fukuhara S, Kurokawa K, Rayner HC, Furniss AL, Port FK, Saran R.

Nephrol Dial Transplant. 2008 Mar;23(3):998-1004. Epub 2007 Oct 1.

PMID:
17911092
27.

Dialysis versus conservative management of elderly patients with advanced chronic kidney disease.

Dasgupta I, Rayner HC.

Nat Clin Pract Nephrol. 2007 Sep;3(9):480-1. Epub 2007 Jul 24. No abstract available.

PMID:
17646857
28.

Starting and withdrawing haemodialysis--associations between nephrologists' opinions, patient characteristics and practice patterns (data from the Dialysis Outcomes and Practice Patterns Study).

Lambie M, Rayner HC, Bragg-Gresham JL, Pisoni RL, Andreucci VE, Canaud B, Port FK, Young EW.

Nephrol Dial Transplant. 2006 Oct;21(10):2814-20. Epub 2006 Jul 4.

PMID:
16820372
29.

Severe acute renal failure in adults: place of care, incidence and outcomes.

Hegarty J, Middleton RJ, Krebs M, Hussain H, Cheung C, Ledson T, Hutchison AJ, Kalra PA, Rayner HC, Stevens PE, O'Donoghue DJ.

QJM. 2005 Sep;98(9):661-6. Epub 2005 Jul 29.

PMID:
16055475
30.

HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients.

Mason NA, Bailie GR, Satayathum S, Bragg-Gresham JL, Akiba T, Akizawa T, Combe C, Rayner HC, Saito A, Gillespie BW, Young EW.

Am J Kidney Dis. 2005 Jan;45(1):119-26.

PMID:
15696451
31.
32.

Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS.

Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW.

Kidney Int. 2004 Jun;65(6):2335-42.

33.

Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, Piera L, Bragg-Gresham JL, Feldman HI, Goodkin DA, Gillespie B, Wolfe RA, Held PJ, Port FK.

Nephrol Dial Transplant. 2004 Jan;19(1):108-20.

PMID:
14671046
34.

Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Hecking E, Bragg-Gresham JL, Rayner HC, Pisoni RL, Andreucci VE, Combe C, Greenwood R, McCullough K, Feldman HI, Young EW, Held PJ, Port FK.

Nephrol Dial Transplant. 2004 Jan;19(1):100-7.

PMID:
14671045
35.

Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW.

J Am Soc Nephrol. 2003 Dec;14(12):3270-7.

36.

Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS.

Saran R, Bragg-Gresham JL, Rayner HC, Goodkin DA, Keen ML, Van Dijk PC, Kurokawa K, Piera L, Saito A, Fukuhara S, Young EW, Held PJ, Port FK.

Kidney Int. 2003 Jul;64(1):254-62.

37.

Orexin as a possible cause of insomnia in dialysis patients.

Rayner HC.

Am J Kidney Dis. 2003 Jun;41(6):1335-6; author reply 1336. No abstract available.

PMID:
12776291
38.

Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study.

Rayner HC, Pisoni RL, Gillespie BW, Goodkin DA, Akiba T, Akizawa T, Saito A, Young EW, Port FK; Dialysis Outcomes and Practice Patterns Study.

Kidney Int. 2003 Jan;63(1):323-30.

39.

A comparison of hospital readmission rates between two general physicians with different outpatient review practices.

Rayner HC, Temple RM, Marshall T, Clarke D.

BMC Health Serv Res. 2002 Jun 25;2(1):12.

40.

Physicians as educators.

Perkins GD, Rayner HC.

J R Coll Physicians Lond. 2000 Jan-Feb;34(1):112. No abstract available.

PMID:
10717894
41.

Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism.

Fletcher S, Kanagasundaram NS, Rayner HC, Irving HC, Fowler RC, Brownjohn AM, Turney JH, Will EJ, Davison AM.

Nephrol Dial Transplant. 1998 Dec;13(12):3111-7.

PMID:
9870475
42.

Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.

Fletcher S, Jones RG, Rayner HC, Harnden P, Hordon LD, Aaron JE, Oldroyd B, Brownjohn AM, Turney JH, Smith MA.

Nephron. 1997;75(4):412-9.

PMID:
9127327
43.

Changes in nutritional status of patients with chronic renal failure on a low protein diet.

Rayner HC, Burton PR, Bennett S, Walls J.

Nephron. 1993;64(1):154. No abstract available.

44.

Effect of cholesterol on the position of segmental lesions in unilaterally nephrectomized rats.

Green NJ, Howie AJ, Rayner HC, Walls J.

J Pathol. 1992 Nov;168(3):331-4.

PMID:
1469510
45.

Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988.

Rayner HC, Haynes AP, Thompson JR, Russell N, Fletcher J.

Q J Med. 1991 Jun;79(290):517-25.

PMID:
1946932
46.
47.

Anthropometry underestimates body protein depletion in haemodialysis patients.

Rayner HC, Stroud DB, Salamon KM, Strauss BJ, Thomson NM, Atkins RC, Wahlqvist ML.

Nephron. 1991;59(1):33-40.

PMID:
1944745
48.

The role of lipids in the pathogenesis of glomerulosclerosis in the rat following subtotal nephrectomy.

Rayner HC, Ross-Gilbertson VL, Walls J.

Eur J Clin Invest. 1990 Feb;20(1):97-104.

PMID:
2108041
49.

Receptor-mediated endocytosis of low-density lipoprotein by cultured human glomerular cells.

Rayner HC, Horsburgh T, Brown SL, Lavender FL, Winder AF, Walls J.

Nephron. 1990;55(3):292-9.

PMID:
2370930
50.

Clinical studies of total body nitrogen in an Australian hospital.

Stroud DB, Borovnicar DJ, Lambert JR, McNeill KG, Marks SJ, Rassool RP, Rayner HC, Strauss BJ, Tai EH, Thompson MN, et al.

Basic Life Sci. 1990;55:177-82. No abstract available.

PMID:
2088266

Supplemental Content

Loading ...
Support Center